Cite

HARVARD Citation

    Yuan, B. et al. (2017). Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials. Cancer letters. pp. 47-56. [Online]. 
  
Back to record